SGS Health Science is a leading CRO providing clinical research, biologics characterization, biosafety, and quality control testing. Delivering solutions in Europe and the US with a specific focus on early-stage development and biometrics, SGS provides clinical trial management (Phase I to IV) services full early phase drug development consultancy, clinical project management and monitoring, biometrics and regulatory & medical affairs services. SGS has its clinical unit with a total of 110 hospitalization beds in Belgium, including a separate quarantine unit with 45 beds for CHIM studies, and has a wealth of expertise in FIH studies, human viral challenge testing, biosimilar and complex PK/PD studies, as well as other regulatory and exploratory trials.
SGS has a large database of investigators and key opinion leaders with therapeutic focuses on Infectious diseases, Vaccines, and Respiratory.
Key areas of focus
Auditing – BioEquivalence – Data Management – Early Clinical Phases – eCRF – Investigator Network – Laboratory – Late phase IV – Marketing / Sales – Medical Advising – Medical Writing – Pharmacovigilance & Drug – Preclinical – Project Management – Regulatory – Safety – Statistics – Training & coaching -Translation
+32 478 27 28 01